Life-sciences real estate is lab and R&D space for biotech and pharma tenants. Coverage tracks specialised buildout costs, venture funding, occupancy and the concentration in a handful of research clusters.
67 live news and deal items, 112 published reports · the 36 most recent span 37 markets and 16 named publishers

Breakthrough Properties, a joint venture between Tishman Speyer and Bellco Capital, has acquired a recently delivered biomanufacturing facility at 215 Shuksan Way in Everett, Washington, just outside of Seattle. The joint venture acquired the 270,000-square-foot property for $78 million from its second life science…
See life sciences research narrowed to a geography, or explore the other property types we track.
Global Real Estate Intelligence is a neutral index of publicly available research. We summarise briefly, attribute every source, and link to the original; all rights remain with the publishers.

Longfellow Real Estate Partners handed its newly completed 210 Adrian tower in Millbrae back to its lender through a deed in lieu of foreclosure, and CBRE is now marketing the 309,461-square-foot building at roughly $120 million to a new class of power-hungry tenants after the life science bet that financed it…

The San Francisco Bay Area's beleaguered life science market posted positive net absorption and a rebound in venture funding in the second quarter, according to Newmark, even as record vacancy, falling rents and a frozen construction pipeline showed how far recovery remains. The post Bay Area Life Science Market…

Malaysia’s IOI Properties Group leads today’s real estate headlines from around Asia Pacific after securing conditional approval for a $1.9 billion REIT listing of nine properties. Also in the news are Australia’s Charter Hall opening a life sciences fund targeting... Read More>> The post IOI Properties Wins…

Life sciences developer Longfellow Real Estate Partners has parted with its first-ever New York City project at a discount. Longfellow’s Hatch Life Sciences Building, located at 43-10 23 Street in Long Island City, Queens, has sold for $86.9 million, according to city records filed Friday. Pearl Realty Management’s…

BOSTON — Ratio Therapeutics has signed a 17,000-square-foot office lease expansion in Boston’s Seaport District. The developer of radiopharmaceuticals for cancer patients will remain at the Innovation & Design Building, a 1.4 million-square-foot mixed-use property that was originally constructed in 1918 as a…

Ipsen Biopharm wants to construct a 400-space multi-storey car park at its Ash Road complex within Wrexham Industrial Estate. The post Global pharma company plans 130,000 sq ft car park at North Wales campus appeared first on Place North West .

A biotechnology firm is relocating its lab space from West Harlem to Midtown South. Volastra Therapeutics signed an 18,120-square-foot lease in the Alexandria Center for Life Science at 430 East 29th Street, owned by Alexandria Real Estate Equities, according to CBRE. Volastra is subleasing space on the 11th floor…

ELIZABETH, N.J. — Osmo, which uses machine learning to digitize scent and promote olfactory science, has opened a 60,000-square-foot headquarters facility in the Northern New Jersey community of Elizabeth. Designed by KSS Architects, the facility includes office, lab and manufacturing space, as well as a breakout…

Alexandria Real Estate struggles in Q2 with $73.7M loss as life sciences market faces challenges.

Alexandria Real Estate Equities captured twice its market share of San Francisco Bay Area leasing in the second quarter, its strongest regional showing, as advanced technology users supplied nearly 30 percent of companywide volume and the REIT closed a $163 million Palo Alto sale to a residential developer. The…
The real estate investment trust said active tenant demand in San Francisco has topped 10 million square feet for the first time since 2019, with the recovery broadening from the city's core into SoMa, the Peninsula and its South San Francisco life science campus. The post Kilroy Says San Francisco Demand Tops 10MM…

Silicon Valley’s industrial and research-and-development markets both firmed in the second quarter of 2026 as artificial intelligence and advanced manufacturing tenants absorbed large blocks, pushed vacancy lower and pulled the region’s commercial real estate fundamentals back toward pre-downturn norms. The…

At the 2026 ULI Carolinas Meeting, leaders from government, life sciences, and professional sports argued that housing, infrastructure, and energy systems—not population growth itself—will determine whether the region can sustain its momentum.

CBRE analyzes life sciences lab and R&D market fundamentals and demand indicators for Q2 2026.

By Kimm Lauterbach, REDI Cincinnati Shaped by its strong German heritage, brewing tradition and historic role as the nation’s pork-processing capital, earning the nickname “Porkopolis,” the Cincinnati region has long been defined by industry, entrepreneurship and innovation. That legacy of reinvention has…

🏆Alteration: The largest alteration filing last week was in Hyde Park, where The University of Chicago secured permits totaling $10 million for work at 5207 South Harper Avenue. Hyde Park Labs is a life sciences incubator developed in collaboration with The University of Chicago, Trammell Crow and Beacon Capital…

This is a news report from EdgeProp Malaysia published in July 2026 covering a capital investment announcement by German life sciences company Eppendorf to construct a manufacturing facility in Penang, Malaysia, with a stated investment value of RM186 million.

Bill Ackman’s Pershing Square Foundation will pay $260 million to acquire two Upper West Side buildings that will house a brain research facility, according to published reports. The foundation acquired 125 West End Ave., which currently houses a 400,000-square-foot life sciences and research campus known as West…

The second phase of Kilroy Realty's sprawling Oyster Point life sciences campus in South San Francisco is climbing uphill in a bid to fill space as the lab leasing market languishes. Although the first phase of the 865K SF campus is 100% leased, the...

A Bothell-based life sciences company was acquired by a Massachusetts firm in a $1.5 billion transaction.

JLL’s Future of Work 2026 survey gathers insights from Corporate Real Estate (CRE) decision-makers worldwide. Responses from Asia Pacific’s life sciences organisations reveal three shifts, drawing on responses from 91 decision-makers across the region: The sector is embracing AI while keeping people at its core The…

A two-building life sciences complex in Boston’s South End traded to its lender as the market’s downturn in the aftermath of the pandemic continues to sink properties once targeting a boom in demand. Blackstone-backed BioMed Realty handed the keys of the adjacent 1000 Washington Street and 321 Harrison Avenue to…

The lenders on a two-building lab and office complex in Boston's South End have taken over ownership from life sciences giant BioMed Realty.

SAN DIEGO — Breakthrough Properties and Tishman Speyer have provided a $90 million mezzanine bridge loan for Aperture Del Mar, a Class A life sciences campus in San Diego. The borrower, Gemdale USA, will use the proceeds to refinance an existing loan. Totaling 538,000 square feet, the four-building lab and office…

The life sciences boom isn’t finished yet. Gemdale USA has secured $90 million in mezzanine debt to refinance Aperture Del Mar, a 538,000-square-foot Class A life science campus that recently opened in San Diego, Calif. Tishman Speyer and Bellco Capital, through their Breakthrough Properties joint venture vehicle,…

Breakthrough Properties and Tishman Speyer announced a joint investment in a $90-million mezzanine bridge loan for Aperture Del Mar, a newly constructed, 538,000-square-foot Class A life science campus in San Diego. The borrower, Gemdale USA, will use the proceeds to refinance an existing loan. The four-building…

JLLの専門家による世界の不動産市場の予測および地域・国別の展望に対する経済・地政学的トレンドの影響についての見解。
The life science industry has climbed out of one of the most complicated stretches in its history, and while the underlying business is healthier than it has been in years, the region’s glut of high-quality but unbuilt lab space remains stubbornly locked up. The life science sector has weathered “one of its most…

Boston's life sciences sector demonstrates emerging recovery signals while maintaining favorable leasing dynamics for occupiers.

Alexandria Real Estate Equities, Inc. has delivered a 427,000-square-foot research & development hub for Bristol Myers Squibb (BMS) at the Campus Point by Alexandria Megacampus in San Diego. Since 1998, Alexandria has partnered with BMS across the REIT’s life science and advanced technology clusters. The initial…

CBRE market analysis of laboratory and life-sciences real estate conditions in Montreal.

DivcoWest said Monday that Collegium Pharmaceutical has signed a headquarters lease for 40,288 square feet on floors 11 and 12 at One Lincoln in Boston’s Financial District, relocating from suburban Stoughton, MA. Slated for the first quarter of 2027, Collegium’s arrival adds a life science presence to a tenant…

GCC focus

JLL examines GCC life sciences clusters and investment opportunities driven by healthcare self-sufficiency mandates, with the pharmaceutical market exceeding $30B and biotech investment topping $12B over five years.

A $40.8 million refinancing was arranged for a 200,750-square-foot manufacturing and R&D portfolio in Wilmington.